[Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].

CONCLUSIONS: In summary, although DTC has a favorable prognosis, in 31% of FTC patients and in 14% of PTC patients, tumor-free status was not achieved. During the median 55-month follow-up period, the disease-specific mortality was 10% in FTC and 2% in PTC. Orv Hetil. 2018; 159(22): 878-887. PMID: 29806478 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29806478?dopt=Abstract

Source: Orvosi Hetilap - June 1, 2018 Category: General Medicine Authors: Szujó S, Bajnok L, Bódis B, Nemes O, Rucz K, Mezősi E Tags: Orv Hetil Source Type: research